Globus Medical (GMED) Non-Current Assets (2011 - 2026)
Globus Medical's (GMED) quarterly Non-Current Assets came in at $3.3 billion in Q2 2026, up 1.29% on a YoY basis from $3.2 billion in Q2 2025, and up 0.97% quarter-over-quarter from $3.2 billion in Q1 2026.
Analysis
Globus Medical (GMED) Non-Current Assets (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported Non-Current Assets for 16 consecutive years, with $3.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 1.29% year-over-year to $3.3 billion; the trailing twelve-month figure through Jun 2026 stood at $12.9 billion (up 4.27% YoY), and the FY2025 full-year result was $3.2 billion, up 3.34% from the prior year.
- Non-Current Assets rose to $3.3 billion in Q2 2026 per GMED's latest filing, from $3.2 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.4 billion in Q3 2023 and bottomed at $1.0 billion in Q2 2023.
- Historically, Non-Current Assets has averaged $2.5 billion across 5 years, with a median of $3.1 billion in 2024.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 225.46% in 2023, then slipped 11.9% in 2024.
- Over 5 years, Non-Current Assets stood at $1.1 billion in 2022, then soared by 190.15% to $3.2 billion in 2023, then slipped by 3.03% to $3.1 billion in 2024, then grew by 3.34% to $3.2 billion in 2025, then grew by 3.01% to $3.3 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $3.3 billion, $3.2 billion, and $3.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn | 3.27 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Bn |
| Mar 31, 2026 | 3.24 Bn |
| Dec 31, 2025 | 3.18 Bn |
| Sep 30, 2025 | 3.17 Bn |
| Jun 30, 2025 | 3.23 Bn |
| Mar 31, 2025 | 3.00 Bn |
| Dec 31, 2024 | 3.07 Bn |
| Sep 30, 2024 | 3.03 Bn |
| Jun 30, 2024 | 3.07 Bn |
| Mar 31, 2024 | 3.12 Bn |
| Dec 31, 2023 | 3.17 Bn |
| Sep 30, 2023 | 3.44 Bn |
| Jun 30, 2023 | 1.00 Bn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.09 Bn |
| Sep 30, 2021 | 930.06 Mn |